Key facts
- Gujarat Superspeciality Hospital (NSE: GKSL)’s last known valuation is $99.9M (Dec 2025).
- It has raised $39.0M; the latest was IPO ($27.9M) in Dec 2025.
- Notable investors include Khandelwal Finance, Sunrise Investment Trust, Venus Investments VCC.
- Status: Publicly Held.
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Gujarat Superspeciality Hospital (NSE: GKSL)
- ·The full record, as it builds
Funding rounds
No funding rounds for Gujarat Superspeciality Hospital (NSE: GKSL) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gujarat Superspeciality Hospital (NSE: GKSL)
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
- Sector
- Healthcare
- HQ
- Vadodara, India
- Founded
- 2019
- Employees
- 670
- Ownership
- Publicly Held
Gujarat Superspeciality Hospital (NSE: GKSL) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gujarat Superspeciality Hospital (NSE: GKSL) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gujarat Superspeciality Hospital (NSE: GKSL) in its N-PORT filings yet. We sweep new filings monthly.